LXRP News and Press, Lexaria Bioscience Corp. From 02/01/21

(TheNewswire) Kelowna, British Columbia - TheNewswire - February 1, 2021 – Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW) (C NSX :LXX. CN ) (the “Company” or “Lexaria”), a global ...

Lexaria Bioscience (LXRP) closes previously announced underwritten public offering of 1,828,571 units at a public offering price of $5.25 per unit.The gross proceeds from the offering were about $11.04M, before deducting underwriting discounts and estimated offering expenses.Each unit in the ...

(TheNewswire) KELOWNA, British Columbia – TheNewswire - January 15, 2021 – Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW) (CSE:LXX) (CNSX:LXX.CN) (the “Company”) today announced th e closing of its pr...

Lexaria Bioscience (LXRP) plans to bring into effect a reverse stock split of its common stock on Jan. 11, 2021.Reverse split will be conducted on a 1-for-30 basis leading to current issued share capital of 90.04M shares being consolidated into 3.00M shares.All the issued convertibl...

(TheNewswire) Kelowna, British Columbia – TheNewswire - January 8, 2021 – Lexaria Bioscience Corp. (OTC:LXRP) (CSE:LXX) (CNSX:LXX.CN) (the “Company” or “Lexaria”), a global innovator in drug deli...

After a recent animal study yielded favorable results, Lexaria Bioscience (LXRP) has initiated the next phase of its antiviral drug research program to evaluate the potential of its proprietary drug delivery technology, DehydraTECH™, on COVID-19 infection.The next phase of follow-on st...

Remdesivir is one of several drugs to be evaluated KELOWNA, BC / ACCESSWIRE / December 22, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that it has initiated the next phase of its antiv...

(TheNewswire) Asset Sale in Preparation for Potential US National Securities Exchange Listing Kelowna, British Columbia - TheNewswire - December 10, 2020 - Lexaria Bioscience Corp. (OTC:LXRP) (CSE:LXX) (C NSX :LXX. CN ) (the ...

Phoenix, Arizona--(Newsfile Corp. - December 8, 2020) - The Stock Day Podcast welcomed Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) , the developer of DehydraTECH™, a proprietary drug delivery technology that improves the way active pharmaceutical ingredients (APIs) enter the bloo...

-Benzinga Global Small Cap Conference on December 8 th -LD Micro Main Event on Dec 15 th -H.C. Wainwright BioConnect, held on Jan 11-14 -Virtual Biotech Showcase, held on Jan 11-14 KELOWNA, BC / ACCESSWIRE / December 7, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the "Compa...